Price Action Alert: Is Inogen Inc’s Fuel Running Low? The Stock Reaches 52-Week High Today

Price Action Alert: Is Inogen Inc's Fuel Running Low? The Stock Reaches 52 Week High Today

The stock of Inogen Inc (NASDAQ:INGN) hit a new 52-week high and has $109.55 target or 68.00% above today’s $65.21 share price. The 5 months bullish chart indicates low risk for the $1.41B company. The 1-year high was reported on Nov, 17 by Barchart.com. If the $109.55 price target is reached, the company will be worth $958.80 million more.
The 52-week high event is an important milestone for every stock because it shows very positive momentum and is time when buyers come in. During such notable technical setup, fundamental investors usually stay away and are careful shorting or selling the stock. About 166,990 shares traded hands. Inogen Inc (NASDAQ:INGN) has risen 32.74% since April 15, 2016 and is uptrending. It has outperformed by 28.12% the S&P500.

Inogen Inc (NASDAQ:INGN) Ratings Coverage

Out of 4 analysts covering Inogen (NASDAQ:INGN), 3 rate it a “Buy”, 0 “Sell”, while 1 “Hold”. This means 75% are positive. Inogen has been the topic of 7 analyst reports since August 12, 2015 according to StockzIntelligence Inc. The stock of Inogen Inc (NASDAQ:INGN) has “Buy” rating given on Wednesday, August 12 by Leerink Swann. Stifel Nicolaus maintained the stock with “Buy” rating in Tuesday, September 22 report. JP Morgan initiated the stock with “Overweight” rating in Wednesday, July 13 report. The rating was maintained by Stifel Nicolaus on Wednesday, August 12 with “Buy”. On Thursday, March 24 the stock rating was initiated by Piper Jaffray with “Neutral”. As per Wednesday, November 11, the company rating was maintained by Needham.

According to Zacks Investment Research, “Inogen, Inc. is a medical technology company. It offers oxygen concentrator, cart, carry bags, backpacks, external battery chargers and universal power supply for obstructive pulmonary disease patients. The Company’s products include Inogen One G3 and Inogen One G2. It sells its products in the United States and internationally. Inogen, Inc. is headquartered in Goleta, California.”

Insitutional Activity: The institutional sentiment decreased to 0.92 in Q2 2016. Its down 0.52, from 1.44 in 2016Q1. The ratio worsened, as 22 funds sold all Inogen Inc shares owned while 54 reduced positions. 18 funds bought stakes while 52 increased positions. They now own 21.40 million shares or 1.51% more from 21.09 million shares in 2016Q1.
Teachers Retirement Sys Of The State Of Kentucky owns 6,000 shares or 0% of their US portfolio. Moreover, Voya Investment Mngmt Lc has 0% invested in Inogen Inc (NASDAQ:INGN) for 6,693 shares. Thompson Davis Inc accumulated 0.01% or 125 shares. Globeflex Capital Lp owns 20,711 shares or 0.28% of their US portfolio. Ridgeworth Capital Mgmt Ltd Llc holds 0.01% of its portfolio in Inogen Inc (NASDAQ:INGN) for 13,513 shares. Victory Cap Management last reported 1,626 shares in the company. Teachers Advisors holds 26,104 shares or 0% of its portfolio. The Denmark-based Novo A S has invested 18.67% in Inogen Inc (NASDAQ:INGN). Northern Tru Corp reported 221,144 shares or 0% of all its holdings. Cornerstone Capital Limited Liability Company has 25,994 shares for 0.01% of their US portfolio. Ladenburg Thalmann Fincl Ser Inc has 100 shares for 0% of their US portfolio. Texas Permanent School Fund accumulated 11,116 shares or 0.01% of the stock. Rice Hall James Assoc Limited Liability Company holds 0.09% of its portfolio in Inogen Inc (NASDAQ:INGN) for 30,353 shares. Price T Rowe Associate Md last reported 0% of its portfolio in the stock. Menta Cap Llc accumulated 0.1% or 14,407 shares.

INGN Company Profile

Inogen, Inc., incorporated on November 27, 2001, is a medical technology company. The Firm is engaged in developing, manufacturing and marketing portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Tags: , ,

Related posts

Leave a Comment